JRCT ID: jRCT2080225250
Registered date:29/06/2020
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 17/07/2020 |
| Target sample size | 6000 |
| Countries of recruitment | Asia except Japan,Japan,North America,South America,Europe |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
| Primary Outcome | efficacy |
|---|---|
| Secondary Outcome | efficacy safety other |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | <= 45age old |
| Gender | Male |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT04199689,JapicCTI-205346 |
Contact
| Public contact | |
| Name | |
| Address | |
| Telephone | |
| JPCT@msd.com | |
| Affiliation | |
| Scientific contact | |
| Name | |
| Address | |
| Telephone | |
| JPCT@msd.com | |
| Affiliation | |